WHO urges to continue to use AstraZeneca’s COVID-19 vaccine

WHO urges to continue to use AstraZeneca’s COVID-19 vaccine.  On April 15th, local time in Denmark, Hans Henry Kruger, director of the World Health Organization’s European Office, said that the number of deaths from new coronavirus pneumonia confirmed in the WHO European region last week exceeded 1 million.

Hans Henry Kruger said:

“The situation in our region is serious; 1.6 million new cases are reported every week, which is equivalent to 9,500 cases per hour and 160 cases per minute. In the past two months, people over 80 years old The diagnosis trend of the population is different from that of other age groups, which may be attributed to the high vaccination rate of this high-risk population. Since February, the proportion of deaths from new coronavirus pneumonia over 80 years old in Europe has gradually decreased to nearly 30 %, this is the lowest figure since the epidemic.”

There are few reported cases of thrombosis among the nearly 200 million people who have been vaccinated with AstraZeneca worldwide. At present, people with new coronavirus pneumonia are at a much higher risk of developing blood clots than people vaccinated with AstraZeneca. There is no doubt that the AstraZeneca vaccine can effectively reduce the hospitalization rate of new coronavirus pneumonia and prevent death.

“We also know about reports of blood clots after Johnson & Johnson’s COVID-19 vaccination. WHO is closely monitoring these reports and will report its findings in due course.”

So far, the European region has received about 171 million doses of COVID-19 vaccine reagents for seven types. Nearly 13% of the European population has received one dose of the COVID-19 vaccine, while nearly 6% have already received two doses.

Hans Henry Kruger said that WHO recommends that countries continue to vaccinate adults with AstraZeneca’s COVID-19 vaccine to protect them from the COVID-19 virus.

(source:internet, reference only)

Disclaimer of medicaltrend.org